Back to Search
DAVID AVIGAN, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1952349243IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
151610(MA)
Education
YALE UNIVERSITY SCHOOL OF MEDICINE
Class of 1989
Research & Publications (20)
Vaccine therapy and adoptive immunotherapy in hematologic malignancies.
PMID 18790443·Best Pract Res Clin Haematol·2008
8-other
Phase I/II study of vaccination with electrofused allogeneic dendritic cells/autologous tumor-derived cells in patients with stage IV renal cell carcinoma.
PMID 17893567·J Immunother·2007
3-trial
Advances in the development of a therapeutic cancer vaccine.
PMID 16280106·J Natl Compr Canc Netw·2005
8-other
Fusion cell vaccination of patients with metastatic breast and renal cancer induces immunological and clinical responses.
PMID 15269142·Clin Cancer Res·2004
3-trial
Dendritic cell-tumor fusion vaccines for renal cell carcinoma.
PMID 15448029·Clin Cancer Res·2004
6-review
Fusions of breast cancer and dendritic cells as a novel cancer vaccine.
PMID 12620154·Clin Breast Cancer·2003
6-review
Vaccination against infectious disease following hematopoietic stem cell transplantation.
PMID 11302551·Biol Blood Marrow Transplant·2001
6-review
Immune reconstitution following high-dose chemotherapy with stem cell rescue in patients with advanced breast cancer.
PMID 10918427·Bone Marrow Transplant·2000
8-other
Allogeneic induced human FOXP3(+)IFN-gamma(+) T cells exhibit selective suppressive capacity.
PMID 19634189·Eur J Immunol·2009
8-other
Direct targeting of the mucin 1 oncoprotein blocks survival and tumorigenicity of human breast carcinoma cells.
PMID 19491255·Cancer Res·2009
7-preclinical
Single-agent bortezomib in previously untreated multiple myeloma: efficacy, characterization of peripheral neuropathy, and molecular correlations with response and neuropathy.
PMID 19528374·J Clin Oncol·2009
8-other
Fusions of dendritic cells with breast carcinoma stimulate the expansion of regulatory T cells while concomitant exposure to IL-12, CpG oligodeoxynucleotides, and anti-CD3/CD28 promotes the expansion of activated tumor reactive cells.
PMID 18566447·J Immunol·2008
8-other
PML targeting eradicates quiescent leukaemia-initiating cells.
PMID 18469801·Nature·2008
7-preclinical
Peripheral blood progenitor cell product contains Th1-biased noninvariant CD1d-reactive natural killer T cells: implications for posttransplant survival.
PMID 18261838·Exp Hematol·2008
8-other
Phase I trial of parathyroid hormone to facilitate stem cell mobilization.
PMID 17580262·Biol Blood Marrow Transplant·2007
3-trial
MUC1 oncoprotein regulates Bcr-Abl stability and pathogenesis in chronic myelogenous leukemia cells.
PMID 18089786·Cancer Res·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 330 BROOKLINE AVE
BOSTON, MA 02215 - Phone
- (617) 667-9920
Quick Facts
- NPI
- 1952349243
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 37
- Publications
- 20
Are you this provider?
Claim Your Profile